White Paper:

Snap Recap: Virtual Panel on Pathways in Europe for US Life Science Companies

On Wednesday, Oct. 21, 2020, Blue Matter Consulting and Greater Zurich Area co-hosted a virtual panel discussion for a select group of leaders from biopharma companies interested in establishing or expanding their operations in Europe. The panel addressed—at a high level—the key decisions that biopharmaceutical companies must make when considering a move into Europe. These include:

  • Whether to enter European markets
  • If entering, which “pathways” to take (e.g., Licensing, Partnering, or “Going-It-Alone”)
  • How to design and staff European operations

The event consisted of informal presentations by two European biopharma leaders and a Q&A session.  This document provides a summary of the session.


  • Hidden
  • This field is for validation purposes and should be left unchanged.